JFIFHH@ICC_PROFILE0ADBEmntrRGB XYZ acspAPPLnone-ADBE cprt2desc0kwtptbkptrTRCgTRCbTRCrXYZgXYZbXYZtextCopyright 1999 Adobe Systems IncorporateddescAdobe RGB (1998)XYZ QXYZ curv3curv3curv3XYZ OXYZ 4,XYZ &1/-Photoshop 3.08BIMxOver-the-counter pain reliever brands of Ibuprofin and Acetiminophen sit on the shelves at the Del Lago Pharmacy in Wilmette, Illinois on Friday, December 17, 2004. Pfizer Inc. said its prescription painkiller Celebrex, which is in the same class of drugs as Merck & Co.'s withdrawn Vioxx, increased the risk of heart attacks in a study of cancer patients. Vioxx and Celebrex were supposed to be gentler on the stomach because they targeted the Cox-2 enzyme that is involved with pain. Older painkillers can cause stomach irritation by interfering with Cox-1, a related enzyme. That difference was intended to justify the cost, sometimes more than $2 a pill, of these drugs, while generic painkillers sell for pennies each. Photographer: Tannen Maury/Bloomberg News zTM/CDP TANNEN MAURYnBLOOMBERG NEWSPFIZER CELEBREX HEART RISK720041217ZWILMETTE_ILLINOISeUNITED STATES OF AMERICA gBUDGET 12/17/04F< 115244-06008BIM%>HF=AVh8BIM8BIM&?8BIM 8BIM8BIM 8BIM 8BIM' 8BIMH/fflff/ff2Z5-8BIMp8BIM@@8BIM8BIM]$PainRelievers01_3328$nullboundsObjcRct1Top longLeftlongBtomlong$RghtlongslicesVlLsObjcslicesliceIDlonggroupIDlongoriginenum ESliceOrigin autoGeneratedTypeenum ESliceTypeImg boundsObjcRct1Top longLeftlongBtomlong$RghtlongurlTEXTnullTEXTMsgeTEXTaltTagTEXTcellTextIsHTMLboolcellTextTEXT horzAlignenumESliceHorzAligndefault vertAlignenumESliceVertAligndefault bgColorTypeenumESliceBGColorTypeNone topOutsetlong leftOutsetlong bottomOutsetlong rightOutsetlong8BIM( ?8BIM8BIM $D~@$(JFIFHH Adobe_CMAdobed            ~" ?   3!1AQa"q2B#$Rb34rC%Scs5&DTdE£t6UeuF'Vfv7GWgw5!1AQaq"2B#R3$brCScs4%&5DTdEU6teuFVfv'7GWgw ?ڀf֍縑Lxn6ѱ<yf8 emj"Rq}̵zz/D̿ QRdٿk Zgz^8h7ܳ&Bޟ= do:=kqaG 㛾ۑm ۚPkeY~ml݊LY 3]=Œ^Eo20vF,[B9/iWy6:5|tS}%oe6ao{ V}-QW%O]FY QqzqGFV5Ww.wvu{ E4>͗KoeO7E&ͲikXʝwwf?D~]7s]c1]K.%}{}o_=q޷RNQ,c'!?4uRuH1fmجOSlv>   *Ω8 "ʕc=Ȏ\v:ٽv~3[ڭ5iDW+gTϰBRЫ3)YkC o5x ni9 |W܋}s)Fcy}G678~Vn epɤA(*.w<!d8${Ʋ\sb{ d.. N#.*vuDZ똵~g;r{Z׺3{y돳*hste}EolcmC(qqʸ~oWe8L՝Q7jeSslYn#)kQeҿ&Tʡlk>;OBljV,\~2q9yVYSdž-cM7}^N?Reð??ljtiޮ `i۰cgڋG.Ͱ2*Q ɭcσ趋 q^R;\'+K[^Ys kc &z8QG1~-Y8s1\_S~u0lkGH$C~zͻ\ka~E9p}k۽it旪7ƨ&; z&n!8jĺ[F]M{轥R'lW.=zkʯ+[G=2Xw;\w%Qp}le}qM r/.(CX"s'>ܧe9kkCJS5G*a{!\K7f䭷{kZ[qH33o\:8ŭkmmisNÿl@!Y(@\ MDq_ۯpv1m kL4]O{w3V`C]cm5q>[1}`f.΂[UE]Bqծi{6u_ͦr2J2቙ p.nb@,cҺ7UzCuOxXw}/Nv[r}lut],7*f%V@q}c,;u/>Z܌: oۃ6`_N$@ֺ0O]ڽG\;U`sGY}5n?U7Z\{[ݻzshg.fCC EswG'ue]e{ݵK\2l{MnnNȮyn鵖͍{ ٰsw{EEٶ#{]&4߿3K7gdtC>lC^-r~~Szmbj&졺he~((o#Ib^z&4Hz?S$RHt"\se̢KXf9fs:v?:g j0o2W;^v:̳{N#΋cl0Cww"7˦ 2YSV khV~o/헷'Ӿ*kƸ%G ~j~8kv#}33}i۩'op6o$5ͪ=wGBz1іm}I#aBRjeNcvL\>=#89./ol7vλbkKb-xfH/qٻo3NA?p VskwR8[elOһW׾S[~XIiNj~Zhʫ8 "tNp=V&^ɿ\l`8ʹ-`(s5J$i l$W+b KTj}S @!!U 4,kK7@@F_Etvӏ]&`h ~O85]au5XE ;[TNG c i#e%=[?IMDdߴ,cZCXVu:Hv?!Di0Sqs_uB=\> mYpkFqZ׿M4w;5A>zls}j g>ˏXlckk ڋ#H6=>zf tޙkAm4ִc+kY.:k:p⡷x-oتtNԲcjv'Je6`mo}WCV0n_V qv?&UjiD'h?zX N'N')lCK\u80NCmYQo~.oU ]Wgus:[ ŵ[sk+ulkvcp",J>22&Xr3Z.V4,ufWc^=~鎾l`e9cC]ύzSFwE>UH<_lkCMk-:ؽfSr*,m7_nvy{ns,ޡK~絬u ~-r.?މD7?ՌRU:m#vh?k8?gf[,ɶ-vCn}\_6F^uU}f7m6f쩯cm#ٿb?ljQ2pO_?^&ޣZ.+y ìu,mFE*áYcC$kwݺŕC)Ipe޳}sO޶[nI}Z3cf?HD_%/݄\pH[7۲ r,`v{ϥ ~hT3CdݍvUi鶵i%+%i~>6ֱ,'7g X^nMDX_^;klw x$rfҌ/^ޟ?7n|axUYOv5fY]Ӵzs?NCjws3a>V1sj*6;!}6WOg^v:.̷7Koxz_2aWK:)^曝e].܌ߡwwzΫX kW.VO0`n:%6̝ם6ْ'k o;*AyԺKiM+eϮR1zmlynuwܯץG"wu|u7uBKG8YLU#2$H?_UhO4tgYXŮDm[cOo^Cﱲ?:?ScX\5N['8,Mw0mG)8rzDƀ?`1x[p:,eLvbnE>.y*nюzm]XoQYʻuV9ًX!^ ~G66Yn 9MaΡ5w?"}W`8T߰a)jfUzm w#oikqel.g@t <3ɝ_L/.9졷H%s\G k} %69&8Ia#^O惿~us*V[X'k^ AZoҎ&P_]5;H(,t⬰(?Hx.RձSYYnֹqە{(i}֝x<,:v!s+b}Χݿ{~_%)] հ˭5?JZO k卑ߓHuªp+'n^G7{jCʇZ[CLloYAgg^j>g;?7Z*8eNzKxc/ni%Dzo"ʥX?H_/խ-,gej3VGƥs{  $?O^p mi5-cuq0׷ճ{?֦^\̀ q1{v% !̖>[@Coɵ==sYޛ7*eLYw.-L9n)h?g7d?hmJ#scv1;RnǯcǨ|L{Nqk3m9]Ahũ۬4Uc;'?gu`eX1g$~﫻a,6W.p$cO[a` $w DLر eh md HbFOe\F$i A^%-e?% OMͭ[Ů˟Ipf؀]\ѐmv}ߙeFd[ѪɴzW: e-Yw%O :Mk(sƙ z{9۵Ao\Ai6qߗn[N!"um˿e`mcak`qBN6MP3$D̵Yak{[[֞M̨:[M7;ٝ`cv~+fꭎl.cvb?<׋n=B*ΠxO"q)k"葨LH_k1u?Bz ak*ZX]i5޵M??"zggqYvߍӪx%ޕMpmmEU\CS}]\-m%$ȴ쭍cw;-6el72kgf{r2[Oo_KdVqkhoheY Xɓr~W]p slyr-%ğ=7 ca X_n?ڍSS V;o̹&$45\|>S2ӯ%]xc0'ow=~bف"|i[vXjƫ4{*7sֵr WFY< G׉vV UE2aoҷMcX8JY-/מljfa%KA-kcmTzS/X,ɷQ!̺Cjkesٳ'u;DdL"5\|fn{efK`ʫq{7#{>\M.87R7\]zEmvopDH-;kz Z{XXI~5ܣ~5Yofm e[ahUi-_61.#comcݟH颼g*wwzbϷrU{ iD}gmSz!§`%mU+XmU6X{,Pjs8{ts!!;6X/kHkKV> 5};Ɯ|]=֐㰴"Ao'7pLDIb˫sp PN:+@ݿC8BIM!SAdobe PhotoshopAdobe Photoshop CS8BIM(ExifMM* z(12; iOver-the-counter pain reliever brands of Ibuprofin and Acetiminophen sit on the shelves at the Del Lago Pharmacy in Wilmette, Illinois on Friday, December 17, 2004. Pfizer Inc. said its prescription painkiller Celebrex, which is in the same class of drugs as Merck & Co.'s withdrawn Vioxx, increased the risk of heart attacks in a study of cancer patients. Vioxx and Celebrex were supposed to be gentler on the stomach because they targeted the Cox-2 enzyme that is involved with pain. Older painkillers can cause stomach irritation by interfering with Cox-1, a related enzyme. That difference was intended to justify the cost, sometimes more than $2 a pill, of these drugs, while generic painkillers sell for pennies each. Photographer: Tannen Maury/Bloomberg News Adobe Photoshop CS Windows2004:12:17 15:19:29TANNEN MAURYР$FN(V$(HHJFIFHH Adobe_CMAdobed            ~" ?   3!1AQa"q2B#$Rb34rC%Scs5&DTdE£t6UeuF'Vfv7GWgw5!1AQaq"2B#R3$brCScs4%&5DTdEU6teuFVfv'7GWgw ?ڀf֍縑Lxn6ѱ<yf8 emj"Rq}̵zz/D̿ QRdٿk Zgz^8h7ܳ&Bޟ= do:=kqaG 㛾ۑm ۚPkeY~ml݊LY 3]=Œ^Eo20vF,[B9/iWy6:5|tS}%oe6ao{ V}-QW%O]FY QqzqGFV5Ww.wvu{ E4>͗KoeO7E&ͲikXʝwwf?D~]7s]c1]K.%}{}o_=q޷RNQ,c'!?4uRuH1fmجOSlv>   *Ω8 "ʕc=Ȏ\v:ٽv~3[ڭ5iDW+gTϰBRЫ3)YkC o5x ni9 |W܋}s)Fcy}G678~Vn epɤA(*.w<!d8${Ʋ\sb{ d.. N#.*vuDZ똵~g;r{Z׺3{y돳*hste}EolcmC(qqʸ~oWe8L՝Q7jeSslYn#)kQeҿ&Tʡlk>;OBljV,\~2q9yVYSdž-cM7}^N?Reð??ljtiޮ `i۰cgڋG.Ͱ2*Q ɭcσ趋 q^R;\'+K[^Ys kc &z8QG1~-Y8s1\_S~u0lkGH$C~zͻ\ka~E9p}k۽it旪7ƨ&; z&n!8jĺ[F]M{轥R'lW.=zkʯ+[G=2Xw;\w%Qp}le}qM r/.(CX"s'>ܧe9kkCJS5G*a{!\K7f䭷{kZ[qH33o\:8ŭkmmisNÿl@!Y(@\ MDq_ۯpv1m kL4]O{w3V`C]cm5q>[1}`f.΂[UE]Bqծi{6u_ͦr2J2቙ p.nb@,cҺ7UzCuOxXw}/Nv[r}lut],7*f%V@q}c,;u/>Z܌: oۃ6`_N$@ֺ0O]ڽG\;U`sGY}5n?U7Z\{[ݻzshg.fCC EswG'ue]e{ݵK\2l{MnnNȮyn鵖͍{ ٰsw{EEٶ#{]&4߿3K7gdtC>lC^-r~~Szmbj&졺he~((o#Ib^z&4Hz?S$RHt"\se̢KXf9fs:v?:g j0o2W;^v:̳{N#΋cl0Cww"7˦ 2YSV khV~o/헷'Ӿ*kƸ%G ~j~8kv#}33}i۩'op6o$5ͪ=wGBz1іm}I#aBRjeNcvL\>=#89./ol7vλbkKb-xfH/qٻo3NA?p VskwR8[elOһW׾S[~XIiNj~Zhʫ8 "tNp=V&^ɿ\l`8ʹ-`(s5J$i l$W+b KTj}S @!!U 4,kK7@@F_Etvӏ]&`h ~O85]au5XE ;[TNG c i#e%=[?IMDdߴ,cZCXVu:Hv?!Di0Sqs_uB=\> mYpkFqZ׿M4w;5A>zls}j g>ˏXlckk ڋ#H6=>zf tޙkAm4ִc+kY.:k:p⡷x-oتtNԲcjv'Je6`mo}WCV0n_V qv?&UjiD'h?zX N'N')lCK\u80NCmYQo~.oU ]Wgus:[ ŵ[sk+ulkvcp",J>22&Xr3Z.V4,ufWc^=~鎾l`e9cC]ύzSFwE>UH<_lkCMk-:ؽfSr*,m7_nvy{ns,ޡK~絬u ~-r.?މD7?ՌRU:m#vh?k8?gf[,ɶ-vCn}\_6F^uU}f7m6f쩯cm#ٿb?ljQ2pO_?^&ޣZ.+y ìu,mFE*áYcC$kwݺŕC)Ipe޳}sO޶[nI}Z3cf?HD_%/݄\pH[7۲ r,`v{ϥ ~hT3CdݍvUi鶵i%+%i~>6ֱ,'7g X^nMDX_^;klw x$rfҌ/^ޟ?7n|axUYOv5fY]Ӵzs?NCjws3a>V1sj*6;!}6WOg^v:.̷7Koxz_2aWK:)^曝e].܌ߡwwzΫX kW.VO0`n:%6̝ם6ْ'k o;*AyԺKiM+eϮR1zmlynuwܯץG"wu|u7uBKG8YLU#2$H?_UhO4tgYXŮDm[cOo^Cﱲ?:?ScX\5N['8,Mw0mG)8rzDƀ?`1x[p:,eLvbnE>.y*nюzm]XoQYʻuV9ًX!^ ~G66Yn 9MaΡ5w?"}W`8T߰a)jfUzm w#oikqel.g@t <3ɝ_L/.9졷H%s\G k} %69&8Ia#^O惿~us*V[X'k^ AZoҎ&P_]5;H(,t⬰(?Hx.RձSYYnֹqە{(i}֝x<,:v!s+b}Χݿ{~_%)] հ˭5?JZO k卑ߓHuªp+'n^G7{jCʇZ[CLloYAgg^j>g;?7Z*8eNzKxc/ni%Dzo"ʥX?H_/խ-,gej3VGƥs{  $?O^p mi5-cuq0׷ճ{?֦^\̀ q1{v% !̖>[@Coɵ==sYޛ7*eLYw.-L9n)h?g7d?hmJ#scv1;RnǯcǨ|L{Nqk3m9]Ahũ۬4Uc;'?gu`eX1g$~﫻a,6W.p$cO[a` $w DLر eh md HbFOe\F$i A^%-e?% OMͭ[Ů˟Ipf؀]\ѐmv}ߙeFd[ѪɴzW: e-Yw%O :Mk(sƙ z{9۵Ao\Ai6qߗn[N!"um˿e`mcak`qBN6MP3$D̵Yak{[[֞M̨:[M7;ٝ`cv~+fꭎl.cvb?<׋n=B*ΠxO"q)k"葨LH_k1u?Bz ak*ZX]i5޵M??"zggqYvߍӪx%ޕMpmmEU\CS}]\-m%$ȴ쭍cw;-6el72kgf{r2[Oo_KdVqkhoheY Xɓr~W]p slyr-%ğ=7 ca X_n?ڍSS V;o̹&$45\|>S2ӯ%]xc0'ow=~bف"|i[vXjƫ4{*7sֵr WFY< G׉vV UE2aoҷMcX8JY-/מljfa%KA-kcmTzS/X,ɷQ!̺Cjkesٳ'u;DdL"5\|fn{efK`ʫq{7#{>\M.87R7\]zEmvopDH-;kz Z{XXI~5ܣ~5Yofm e[ahUi-_61.#comcݟH颼g*wwzbϷrU{ iD}gmSz!§`%mU+XmU6X{,Pjs8{ts!!;6X/kHkKV> 5};Ɯ|]=֐㰴"Ao'7pLDIb˫sp PN:+@ݿC& http://ns.adobe.com/xap/1.0/ 2.0 _DSC3328.NEF As Shot +1.20 3 66 +25 0 25 0 25 0 0 0 0 0 0 0 0 0 0 1/25 4643856/1000000 4/1 4/1 1 2004-12-17T14:04:18Z -133/100 3/1 5 14/1 2000 1572 False 0 200 4294967295 14.0 mm f/2.8 TM/CD BLOOMBERG NEWS WILMETTE ILLINOIS UNITED STATES OF AMERICA F 2004-12-17 BUDGET 12/17/04 NIKON CORPORATION NIKON D2H 1 200/1 200/1 2 2004-12-17T15:19:29-05:00 2004-12-17T13:45:58-06:00 2004-12-17T15:19:29-05:00 Adobe Photoshop CS Windows adobe:docid:photoshop:89026269-505a-11d9-a5a4-daea6a563e65 image/jpeg Over-the-counter pain reliever brands of Ibuprofin and Acetiminophen sit on the shelves at the Del Lago Pharmacy in Wilmette, Illinois on Friday, December 17, 2004. Pfizer Inc. said its prescription painkiller Celebrex, which is in the same class of drugs as Merck & Co.'s withdrawn Vioxx, increased the risk of heart attacks in a study of cancer patients. Vioxx and Celebrex were supposed to be gentler on the stomach because they targeted the Cox-2 enzyme that is involved with pain. Older painkillers can cause stomach irritation by interfering with Cox-1, a related enzyme. That difference was intended to justify the cost, sometimes more than $2 a pill, of these drugs, while generic painkillers sell for pennies each. Photographer: Tannen Maury/Bloomberg News PFIZER CELEBREX HEART RISK TANNEN MAURY C  !"$"$C" W   !1A"Qa2qB#$RbrV%34CS҅DTst2!1"AQaq2#B ?M#嚶M*"@t}6J`G r[zmBHΟ|\p2> zd]vN5d)Oj+,dBMq{g k[JV/;Eշ/to ^ _UԶyRu[]~3sIR[f \9ɶt 4e^SA/R Qx Z[ee]SitW&tHz=7P^ǑKtG&(}jk'.g?aReMR2i]=۔I)(CQ~Iȼ*HϬNٳ7Muk\u[ &riQ8G&[E;;2.?QN6R pګRyC|_V>LZe$6a Jn6#V( o`-ce$%QyԮK3rzXn/߿l/ ;w{asSEAED85(%’)*opR8;FI)݃F4I9WClj_[q!f!UY/TrFe&2Y6>en Re?)O| ksX_J q9y%\OZos?oi7)#zNd+aw+ljdr\5A8֛l2SZ>q*$~/jy Ww IR5?i ?ZozC'BalD[l7S=(Y;9.e>Jչ\V\WjRԵŗ"˞љg!ؘ`2%`^p,҇։A,{r_|y⡭1NԤ9Kpe( E}ٱe1,o9HSY4Yv֜rW 0FmfwP\TZKZZZ g6gZD; -bxTf2m-[|1 RN-ʓjr?4#}IJ EʍSs DTB$I(r<%Q}C~4U_WC45lOO䥥K.,$\$Cè8&l$xs[ԅ,6P%^p%ئ)"9i: tJiy ^#|VkB;Lt7! 7*F[=yBTYM$5 2fj* `7!4,\\J͖I⋋E/ާ;&LxĕIZװxU,S ցu& e [@=R1.B 'qR7:_2O5y%Da*.ҵʮGHR)w`Mg.գ6/:YP*鰽0߮!ʅR^qf@JÉJmp|n1U0ٌa{>6O #BJxAX[_PeJ7*QVm ͚CQ'ZKHX{k#UqqSҧ it*fU.r4vzѦ-7K hon ϯ4l~?h$]:>6joħdJo~ZI*6<ڕGP ΗPPbb®%*yrReN!)h o pc|8 J4F $e}c2H1QW<.xw>!$#)Mm'Ma3윾P̚JtFp5F<9%!b|lx =J%, rLϕaQY\sYQ2Ѝ*ۡ6=~@K+J#-oL_TUx.*KEP *m(%:RRM#OeyT8E"q%`!jV#} x7r>\ܡHߢ幮z<Tޒ]6r.N[Ui H.\•*ڷҢ.o"f*%~]-}ȮE-en V֭w5ڳS -ݧ9ds[k?E?nOO'Kq>I!ҳr[*J Kf$foe1y? (:Tv6)E6E̹mbU s:+) B4v|f+ө*Twesr%* b)V8/ct"AINd:5 ae 򣸐BʁJ5$\M૨]2}<-yG.zЈ.6-\6$%`Q⽯d"jTiii()h6b{mo6@R!۠'1}'i%*+_fxg1U +C1)$m8syoIUp\QIu Q*C/T V9ƫYuʢ$-*VئV*CRJqۦ2H]PCA:$|:[J:?0LTCFK(#OxxFdʼSoH?e߉EBA1׹z .Ml\AQ=-l2y.Q4 CAK?78Ef>7TօFD-2nRpl:bCO-4эqG.%^dɧ\Ud2qR4X-E+ (BVh{STeElSG) µ !Ȁ,wJW,\P1#;S5N -,kmk~x<:9nLIۍ$$,SD=ab@MhoPNƴuG3`w5-րRs{}il<<dr哥*A iY$ʑ2M>DDjԠ I )ⷈ13ZKkqK̿#KBCiN* Z -VzK #¤$Bo:Nvֹ n"Obrs6B͊$0 In+<*J!HC$jD Yy BVZ$8m,,"&)qi^Ki(~QEF)aG ];_{*mZ5'(=htLls9LӍ4 Q))扸I#.LaNa+m"؁e @@mBw%`or9p@MHUۤ ]b] <9h.1Pak-Tw|bL4L%1J͒n>-[}['Qm$Im+f":]ĥ@\Qn|[Ӡ9CVX[,%J*JҶ!Db #Ѐ6ÿrǒ#I=.{s9Zco yb#rMnMmQ5q!֚ij Z(s0f Pur[݀iBUp@\k$U>NKiPt(%ZN.l拎ߤ11%>LhT,֛u-F&*D0-k z4lI[ 0*JIRPtMNxOm%9P7sb:p2 BnӹE p8Aҡ}A=H"3\I C\R%*IA&ŏ\Q7e赉*SYSkiA(N5=80y&L$ y ДRln7nEÚ!Te)n̓:Kn4EoߦКÎ)igIJSIAeVU)YQi/=6H6mV'WyKQK" e):FmόtSu4Ff)-&M^ .IkXZMWUU mZPm+s{[ ͨ) Ȓ5qZtݴY#L~DPy7%!;xvt"@C*5 "G\xϪ-lܓjSr+NIjsM|ItJ{,GU(qծKN~SkKvJ GhSM$ﵷs(7RSTck~\v\ 6SC DjthVm.㓸ԘtFS\ +rJ僨'Jmq;i<*c_Ii)Am//Caj`B¹/#frb*!$ljMQH !?Gs- u /+'GۮI깒Jr_ t?8)LU]F'_HlO}n@د(49soRcbAlWG4qhL Th&: FH*L=6ܒwi_|sW|-Q#ed#%8֕To`FڭaJ%܌ 7Q4  &ي~GN>{}S$al} ܟ1%^bk>ЙQԅ+*]$\P5jiNd_ʝ-+ }.6J 䤎¦g8r*.k_1S>dZ&G0d~RqX۩-jV[-5*SSP{,NiQ >j2e%MIp#?Gk`eϖ[T˩].LhoԷa拘r.vwJzS!hqlB>vAN(61jT\[r#@~J.REE `vnpʧ*KSn-8ΕX7.:ᣖq2֪ID5V a]6)6< ϒ=զSu DuX3YZ fT9dF%i*!GYQ)6pmUcs+S,6uJLCteٶDE%8/BM*/`>O5]69Џqm!iEEEI7 醎ji(ea+J`:EiC.Hh3 I'ج6%w mf[ywK"[CIv$)i'ajo4TlG|IK2\u:yӥ ś~rHef,-qou,5#A\[5M*Cn嶒}IHĜXrdUyK[ R!6)-mjIy IUQjӜB:HTQ>)M,RϩGL**1@ CNv w튚nr,֩=ښz)J@;''lCIniY-$}=T NKwr;#[c*rFJPĆe)r(RWԬt jN]FZ#*]Fz v7z%[eȠ G hHծQ5)u&9%1^SJ)a,|FCl*)^Esc͐^#`S˱|%FJi9CH .v8(.r^/;4vJELuɧ%!Ş/U_dv4I9QShΐ 1yp1:-Рb2RF)V3g,;UgדG RTAlKruJZ6_ᬊ hJt%AD2]E̿$ZYtcաWJ:l'P\FYP5*9r'|7KPV0Κ->0Q'H`628l5خ!^8ia>*fA(?SSdhpl)iJ ow$`mھbaqW+:RoĩS4J9ҷ$6zuO5d9Uf,O(ڊxJ4 TiQC*-B.ćUD֤s$) HH=qK\>TfGGTDj:W7 doznf=V㔕:ڭm*5P_}*ܴN}IR(ӾJ\|$zi4j|Nɹ3/T 8*;(R(qBYQJ2dz%IWk߾-Գ R˚ԕ-)v#lP@E"ceuoJ"m`/놁>_~c2]C,($ssԟ q6E匮u!A~3*nF1V_BRs$9Fu3[|16\6KreѸPjn\UTc!qVQr[UR\ealxFtJXP%ZJ R Ӗ2g+&7#V Ö$Z!;-NpR:Ld  jJgM}vSJZ%LVXy){,@{6mYr4`֑&k]}jRØ֓ew#0* j)jLu @<Ԓ5$ߨt+"bhZ^V%zj {be+>\df/󕭻 15vBWkߨ&4j`(:`: |C{{;v5[A<qQr5.+[6JM)co=GГ:v q*PDp<6AM?*D%'QKĔJl vc *4ӡ8Fu8=7JTf*JOKAd$Z_^˹""Ya&"L5%)~ۮ/WTX}Iaa|c3R.31R!pҬ>m)]U6G%vfO]IK, *"dz6YzuI,,j~æ55:NezH&M9ЇT$=[ᵙg63ȐʖiAJKD˙>V*ݏ\RCyN.PS2߁;PFَ={*3HP]]d,O熥 8Җ*Nk*GdW95G hS)Ym3K)L"0M;|Wl436a!&%7*IԦSe$(5( <ә4Ijܥ8/ ^3PDڸ\   ѽRC \SCS8]'Mjߘ1Փ u+ zoh]6j6M&)m%ev*ҕ' gjU uC2eQlPZԍjIؤ O%?$)OBPbN\bS񃌨4l RQdL*$ ^ tCTޜke*B{lDX ]11Qcnd (ˢCSiPZKcUrD EB)/F}SZ,/n}aZD]yT^6Mr<&MyJܑ$@DUtk):+n&#{5)n ? +#$e ꄲ_*X!QRYx^cn v!\ RP(\LV j*J I [@~+0҅( ,Xi>BQa| 8]HyZ6~!'i)%A7OO#25.Z %ؒP2v/nr*KH<6 ذ]cy8js(@}e҇hm.N^~QuJ-Jx~.mhނ'Vbf;R '-2- PMt4` VSF{hQ}ܘΧSnȏ?\t^Dy.C֦Q^3 )YXJTa >=촺<6RIR"e]Kjp('ڪ10֩ID2 ")WF1_TVxZRUE %%`$((,2Vr eQNOTj6EaMɏXTEGc8_yw+ ]FT)Mr.7Jm4ܴ8x;*-q.i8Nu OeSIa67,@ethFڈkY ▧8 XRQuYj; 爴(IJpήJK\8BT OtE_ڴ p{o{{-1n)reNDCHCyh7uq`V[ˎ8\jZҒ< Y̤4M#4동3Tp[Rc;iy:⹏٦҄l/?;_ TRi` ApZ9a қE[_-j\%2!]A-hP7ĞGǼś.:YP$6T]n3JQzN]MgRЗڎqJX:JRIQҐ.vzcu1K9Rrz,u-)Nh =Gׁ4FOC."G}\jBBc{_n>UlGe 5[imEtZB4ccN! -)*ʬtv*ϯ/9OJV #yuHN ӈvnT.J^@ Q@IA,&ZTؽ̜Ie(APȻwJPE􎶶C4lŝko>,Ƥa1PZd6ꓡ$Q%׬Tm#bR\ʩ]:]1ƩKi |H;= עips osϦ-0A~(ΨV/seR~+hW;wL>Wfu)H /0ҕ-ײSpROy+)mrT IuvpY~r9mJS.vN\-ޮmC4x?-T;K"}4 Oe$[@[ Zd6Ÿ|b\Z-N eQ)zߋ#ud\QjSΆ 5Kq䆁?>8ڵB\tMO?N!@MT,8+OU9]@ȒpJ E$I=u>OS)ip@0غmcOsnSXn7 ZT!e o7aE1^*o#KǨo>̜Vn]#n`$A=PNAAER'xo)_{޸UWrUDžL7VS zC,%ZR֠6,aNaXK\2tLiw'&]a UVdEMe֡&9(b+.ADVcNVIF`H0GXL͔af=:@iZ Ӿ<|ZweHm>Cex\) fB '鵺aL;;+yuwRvD5GNDYSJV\M|Hzs@ d }.>Rr#)CU^TRV6PA6$AUrd~K.k7&V/ 7&wQVԗ^W,}q1V ~qܢll1+`kPזd %=,;$U r Z IoNQ$nk}-7uIZ'歳6N %1K sCl[xץk Hܛt7Im-9]!k |$J }Q!l7qӳi-~8s*CO { jBRcJO{xf- .rI-L!r]qcD)$Z_rO jf4PZQvsQ&ʹ K v>*S,&<"r+i%IBaavǚY-WT0%J)R)8l>Śj{Cߙ[ZQ"h{JZiTM3RD.")CHT%IP jܺ3&A!1) X з0v#IK%>G7ܟSio(8q1f>jOXD5}Wmlmkd4 ԥ_.S%DK$᳒rTI/6KF,%N|>ajƕەGÌ-Z.y~F۶4,MI59N|6֔6HnDŽNֽ鉯YL0r m`:e/Ea2[,) l0Mol32yL:!FiHEQ{u7V& R[PU-E[E)p:RzB\37"}% ~_uВ.h6أsJ68UTQODJem-VLG.2r*1Z|f+&7?eъiXK(*AR~f-?7)w3`-G] 8TKeLȥD)Z'*x521Ш$IRRݼ'^Z5Ih%Hdon6X&;V<O'uXwc"Pj;eՅ\T<̫[͏!m'ͷNa6\NͿ5#Ŀ`G6-mJs,U`r9RjArSkmԭw(uD˫!ZMNb-n;Y,˘%m:M/%5 өKP6R;$zᗗTm\ftBAR \;T-qq.CAxє(DgΘ `Ʈ3 sL*Q(@h }޶NQs)IQuB}#~cNV~6$rcNJT+RQ"ۧ-o;|Sm_1eD@Jm c#rT[~Am@A֖ תڴol3 ՊUϚJcZBJq˫mOM n[>LvS}ݧkW\wXDt& J7USJҥͱ~x6 Jqٰfʑu ikjV 8Q1cǧ캈2Zb.SaI;xVeiJNϵ`f9 u:o>᳅0 H`}=|+mt%2sR^)ئopC =QRPVH#-'ƚO=&Fesl뤝yAiA((p?~L}(ո [L[p0D<6磊s6K.*?z~jxҤ($ҙс7_ Wi.'%PsR69"+Ct$f<"QMf~kFi,Wa>@nq 9%v ܞcR!"Q'钂?{$cqoL7cΥŒ6ԊQ{oMsI$)1Rh(KT(1%Z$uly=QNh唶$TԧJP@E1#kz9VҚĐailCFYG܁<]Tc9)S)7i^s5u\(3_bJT-Uim_RƉTifMiy:ʸR:GL`$.V).z%=1h1J'*Oh3Ti6F)V;_3}SOj7 mx#`誩tDESkK|}QEu:,EpI2o[,$(b}n?fieѪ1ykicQK"4s+*JarbeTyy3ӕ"7i !) "]]ef+#y)1+H)(7uj* Q>ۍN'ułN$sԝ>f,fPD/q5% h7I[i];l^5msZ"[ nqBxyqꤐ!^P:#A~cq(=0@ǴwHKy!3-ivb.c*H〵Z8s|Av1gR\Q;n]f)Ԙi^ !\=MnJ YC%a)ґr: Ԝ@񯉵Ky0 0 7mSmAb lTI#X~"Ԕƒʙu-b(Xb1/ۊ~e37*)D*6"Vk(UV| ({ɕ\W VR_3JGHLlEeL0jV+asc1f 8*lrVŕZVVO_a6v⤉Kw3 Z)|<ǽ`R`^w*Ĭ[I ~l2D@`: E4$5.3@YXsh=jIvk\BkS2;N3Ef lgI?bbn`X[f hҢ.;n6 Jwk\f3o>]Ns;͐嵯HM@1f"